Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model (2024)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidade: ICB
- DOI: 10.3389/fnana.2024.1511951
- Subjects: FISIOLOGIA; DOENÇA DE PARKINSON; ATROFIA DE MÚLTIPLOS SISTEMAS; CITOCINAS; DOENÇAS NEURODEGENERATIVAS; MODELOS ANIMAIS DE DOENÇAS; CAMUNDONGOS; IMUNOHISTOQUÍMICA; ELISA EM ANIMAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Neuroanatomy
- ISSN: 1662-5129
- Volume/Número/Paginação/Ano: v. 18, art. 1511951, 12 p., 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BIANCHETTI, Maria Eduada Goulart e FERREIRA, Ana Flávia Fernandes e BRITTO, Luiz Roberto Giorgetti de. Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model. Frontiers in Neuroanatomy, v. 18, p. 12 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fnana.2024.1511951. Acesso em: 27 dez. 2025. -
APA
Bianchetti, M. E. G., Ferreira, A. F. F., & Britto, L. R. G. de. (2024). Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model. Frontiers in Neuroanatomy, 18, 12 . doi:10.3389/fnana.2024.1511951 -
NLM
Bianchetti MEG, Ferreira AFF, Britto LRG de. Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model [Internet]. Frontiers in Neuroanatomy. 2024 ; 18 12 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fnana.2024.1511951 -
Vancouver
Bianchetti MEG, Ferreira AFF, Britto LRG de. Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model [Internet]. Frontiers in Neuroanatomy. 2024 ; 18 12 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fnana.2024.1511951 - The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Mitochondrial abnormalities in neurological disorders
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- The role of interleukin-17 in neurological disorders
- Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
- Efeitos do exercício físico na função e biogênese mitocondrial em modelo de doença de Parkinson induzido por 6-hidroxidopamina
- Association between thyroid function and Alzheimer’s disease: a systematic review
Informações sobre o DOI: 10.3389/fnana.2024.1511951 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
